You’ve been the CEO since June; tell us about it.
I assumed the position of CEO at Trimb in the middle of June, just as we completed the acquisition of Pevaryl and Fungoral from J&J.
Stockholm, January 7, 2019 – Trimb Healthcare AB (“Trimb”) has successfully closed its previously announced acquisition of CCS Healthcare Nordic AB’s (“CCS”) portfolio of skin care products in Sweden, Norway and the UK (“CCS Skincare Brands”). The portfolio includes several well-established and highly recognized brands, including CCS Swedish Formula, Indy Beauty, Oliva, Bamse, and exclusive rights to DAX and Antibac in the consumer sales channel in Sweden. The CCS Skincare Brands’ sales and marketing organization in Stockholm has also been transferred to Trimb.
For more information, please contact:
Magnus Nylén, CEO Trimb
Phone: +46 70 514 84 94
Anders Larnholt, VP M&A Trimb
Phone: +46 76 677 64 95